Cannabis hyperemesis syndrome is on the rise: What symptoms to watch for – The Hill

WHY IT MATTERS: If you use cannabis daily and experience recurring vomiting that improves with hot showers, you may have cannabis hyperemesis syndrome, and stopping cannabis use is currently the only reliable cure. CLINICAL OVERVIEW: Cannabis hyperemesis syndrome (CHS) is a paradoxical condition in which chronic, heavy cannabis users develop cyclic episodes of severe nausea, vomiting, and abdominal pain, often relieved temporarily by hot showers or baths. The syndrome is frequently misdiagnosed for months or years because patients and clinicians alike associate cannabis with antiemetic properties, creating a counterintuitive diagnostic barrier.

Read More

Cannabis hyperemesis syndrome cases surge in Virginia ERs – YouTube

WHY IT MATTERS: If you use cannabis regularly and experience recurring nausea, vomiting, or abdominal pain that temporarily improves with hot showers, you should talk to your cannabis clinician about adjusting your dose, frequency, or product potency before your next ER visit. CLINICAL OVERVIEW: Cannabis hyperemesis syndrome (CHS) is a real clinical condition characterized by cyclical vomiting, nausea, and abdominal pain in frequent cannabis users, and emergency departments across legalized states are reporting increased presentations. While CHS can be distressing and even dangerous if dehydration becomes severe, it is almost always associated with very high-frequency, high-potency use and resolves reliably with cessation or significant dose reduction.

Read More

Researcher: Remediated cannabis may still have harmful mold – MJBizDaily

WHY IT MATTERS: If you are using cannabis purchased from a dispensary, you should know that passing a state lab test does not guarantee your product is free from all harmful mold species, which is especially important if you have a weakened immune system or chronic lung conditions. CLINICAL OVERVIEW: Recent research highlights that cannabis products which have undergone remediation processes to address mold contamination may still harbor harmful fungal organisms that current state-mandated testing protocols fail to detect. This raises significant clinical concerns because immunocompromised patients and those with respiratory conditions may be unknowingly exposed to mycotoxins and viable mold spores, and the assumption that vaporization eliminates these contaminants appears to be unsupported by the evidence.

Read More